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Preventing farnesylation of the dynein adaptor
Spindly contributes to the mitotic defects caused
by farnesyltransferase inhibitors
Andrew J. Hollanda,*, Rita M. Reisb,c, Sherry Niessend, Cláudia Pereirab,c, Douglas A. Andrese,
H. Peter Spielmanne,f, Don W. Clevelanda, Arshad Desaia, and Reto Gassmannb,c
a
Ludwig Institute for Cancer Research/Department of Cellular and Molecular Medicine, University of California, San
Diego, La Jolla, CA 92093; bInstituto de Biologia Molecular e Celular and cInstituto de Investigação e Inovação em
Saúde-i3S, Universidade do Porto, Porto 4150-180, Portugal; dSkaggs Institute for Chemical Biology and Department
of Chemical Physiology, Center for Physiological Proteomics, Scripps Research Institute, La Jolla, CA 92037;
e
Department of Molecular and Cellular Biochemistry and fDepartment of Chemistry, Markey Cancer Center, Kentucky
Center for Structural Biology, University of Kentucky, Lexington, KY 40536

ABSTRACT The clinical interest in farnesyltransferase inhibitors (FTIs) makes it important to
understand how these compounds affect cellular processes involving farnesylated proteins.
Mitotic abnormalities observed after treatment with FTIs have so far been attributed to defects in the farnesylation of the outer kinetochore proteins CENP-E and CENP-F, which are
involved in chromosome congression and spindle assembly checkpoint signaling. Here we
identify the cytoplasmic dynein adaptor Spindly as an additional component of the outer kinetochore that is modified by farnesyltransferase (FTase). We show that farnesylation of Spindly is essential for its localization, and thus for the proper localization of dynein and its cofactor dynactin, to prometaphase kinetochores and that Spindly kinetochore recruitment is
more severely affected by FTase inhibition than kinetochore recruitment of CENP-E and
CENP-F. Molecular replacement experiments show that both Spindly and CENP-E farnesylation are required for efficient chromosome congression. The identification of Spindly as a
new mitotic substrate of FTase provides insight into the causes of the mitotic phenotypes
observed with FTase inhibitors.
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INTRODUCTION
A wide variety of proteins, including RAS, pre–lamin A, fungal pheromones, and rhodopsin kinase, depend on posttranslational prenylation for proper localization and activity. Prenylated proteins are
modified by either farnesyltransferase (FTase) or geranylgeranyltransferase (GGTase), which covalently link a 15- or 20-carbon
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isoprenoid moiety to a C-terminal cysteine via a thiolether bond,
with farnesyl diphosphate (FPP) and geranylgeranyl diphosphate
(GGPP) acting as the lipid donors (Pechlivanis and Kuhlmann, 2006;
Nguyen et al., 2010; Zverina et al., 2012). FTase and GGTase type 1
have been proposed to recognize protein substrates containing a
C-terminal CAAX box, where C refers to the modified cysteine residue, A is any aliphatic amino acid, and X refers to a subset of amino
acids that determine whether the cysteine receives a farnesyl or geranylgeranyl group. Besides facilitating association with membranes, the farnesyl/geranylgeranyl moiety has also been shown to
be involved in the regulation and modulation of protein–protein interactions (Hoffman et al., 2000; Rak et al., 2003; Rotblat et al.,
2004; Pylypenko et al., 2006; Ignatev et al., 2008).
Oncogenic mutations in the RAS genes constitutively activate
GTPase activity, leading to uncontrolled proliferation. Farnesylation
is required for the translocation of RAS to the plasma membrane
and subsequent activation of cellular signaling. The promise of inhibiting the membrane translocation of oncogenic RAS spurred the

Supplemental Material can be found at:
http://www.molbiolcell.org/content/suppl/2015/03/23/mbc.E14-11-1560v1.DC1.html

1845

development of potent farnesyltransferase inhibitors (FTIs; Crul
et al., 2001). However, studies with these inhibitors revealed that RAS
undergoes alternative geranylgeranylation that is capable of promoting membrane translocation in the presence of FTIs (Berndt et al.,
2011). This has limited the clinical use of FTIs as anticancer agents,
although recent evidence suggests that FTIs may be valuable in the
treatment of malignant hematological disease (Berndt et al., 2011;
Holstein and Hohl, 2012). Of importance, the use of FTIs is not limited to cancer therapeutics: inhibition of FTase has gained interest as
an approach for fighting parasites (Eastman et al., 2006), and FTIs
have shown promise for the treatment of Hutchinson–Gilford progeria syndrome, a disease caused by the aberrant accumulation of a
farnesylated form of lamin A (Yang et al., 2011; Gordon et al., 2014).
The medical relevance of FTIs makes it important to identify the
cellular substrates of FTase. Most human tumor cells lines that are
sensitive to FTI treatment exhibit a defect in chromosome congression that leads to an accumulation in the mitotic phase of the cell
cycle (Moasser et al., 1998; Ashar et al., 2000; Crespo et al., 2001;
Schafer-Hales et al., 2007). This effect has been attributed to nonfarnesylated CENP-E and CENP-F, which are the only mitotic substrates of FTase known to date. Both CENP-E, a microtubule plus
end–directed kinesin, and CENP-F, a coiled-coil protein implicated
in the recruitment of cytoplasmic dynein, localize to mitotic kinetochores, where they are involved in mediating attachments to spindle
microtubules that drive chromosome segregation (Weaver et al.,
2003; Bomont et al., 2005; Feng et al., 2006; Liang et al., 2007;
Vergnolle et al., 2007; Kim et al., 2008). Farnesylation of CENP-E
and CENP-F is required for their APC/C-mediated degradation at
mitotic exit by the proteasome (Hussein and Taylor, 2002; Gurden
et al., 2010). In addition, kinetochore localization of CENP-E and
CENP-F has been reported to be impaired after FTase inhibition in
some studies (Hussein and Taylor, 2002; Schafer-Hales et al., 2007)
but not others (Ashar et al., 2000; Crul et al., 2001; Verstraeten et al.,
2011). Thus the contribution from the lack of CENP-E and CENP-F
farnesylation to the mitotic phenotype of FTIs remains unclear.
Spindly is a kinetochore-specific adaptor for cytoplasmic dynein
(Griffis et al., 2007; Chan et al., 2009; Barisic et al., 2010; Gassmann
et al., 2010) that, like CENP-E and CENP-F, localizes to the fibrous
corona, the outermost domain of the kinetochore, and is removed
from microtubule-attached kinetochores by dynein-mediated transport to spindle poles. Here we identify Spindly as a novel substrate
of FTase in human cells. We demonstrate that Spindly physically interacts with FTase and show that farnesylation is required for Spindly
accumulation at kinetochores. Functional replacement experiments
show that preventing farnesylation of Spindly and CENP-E delays
chromosome congression, producing a phenotype similar to that
observed in cells treated with FTIs. The identification of Spindly as a
novel farnesylated kinetochore protein provides mechanistic insight
into the biological effect of FTIs.

RESULTS
The kinetochore protein Spindly is a substrate
of farnesyltransferase
To identify binding partners of human Spindly, we immunoprecipitated Spindly from mitotic HeLa cell extracts using two affinity-purified polyclonal antibodies raised against nonoverlapping epitopes
in the N- and C-terminal halves of the protein (Figure 1A). Both antibodies immunoprecipitated Spindly with similar efficiency (Supplemental Figure S1), and mass spectrometric analysis identified the α
and β subunits of FTase in a search for proteins that coimmunoprecipitated with both antibodies (Figure 1A). By contrast, the known
kinetochore components Mad1-Mad2 and CENP-F were pulled
1846 | A. J. Holland et al.

down with only one of the two antibodies (Figure 1A and Supplemental Figure S1). We conclude that a mitotic pool of human
Spindly associates with FTase.
Sequence inspection revealed that Spindly contains an atypical
variant of the C-terminal CAAX box (Hougland et al., 2009) that is
conserved from vertebrates to fungi (Figure 1B). Of interest, the motif appears to have been lost in a subset of phyla, including the invertebrate chordate group amphioxus (Branchiostoma floridae),
hemichordates (Saccoglossus kowalevskii), insects (Drosophila
melanogaster), nematodes (Caenorhabditis elegans), and cnidaria
(Hydra magnipapillata).
The physical association of Spindly with FTase and the conservation of the C-terminal farnesylation motif suggested that Spindly may
be modified by FTase. To test this directly, we incubated cells with
anilinogeraniol (AGOH; Figure 1C), which is converted to the unnatural, competitive FPP analogue anilinogeranyl diphosphate (AGPP)
and incorporated into proteins by FTase (Troutman et al., 2005). The
AG moiety in proteins can subsequently be detected with specific
polyclonal anti-AG antibodies. Consistent with farnesylated proteins
being present at kinetochores, we detected AG signal at kinetochores by immunofluorescence (Supplemental Figure S2A). To assess
farnesylation of both endogenous and transgenic Spindly by immunoblot, we used HeLa cell lines in which tetracycline-inducible
MycGFP::Spindly constructs were integrated into a specific genomic
locus by Flp-mediated DNA recombination (O’Gorman et al., 1991).
We had previously implemented this system for the study of Spindly
mutants (Gassmann et al., 2010). As a negative control, we mutated
the putative farnesylated cysteine residue to serine (C602S). We
incubated cells with tetracycline and AGOH for 48 h in the presence
or absence of the FTase inhibitor FTI-277 before preparing cell lysates
and immunoprecipitating transgene-encoded Spindly with anti-Myc
antibodies (Figure 1C). Immunoblotting with anti-Spindly antibodies
revealed that endogenous Spindly efficiently coimmunoprecipitated
with MycGFP::Spindly (Figure 1D), suggesting that Spindly is present
as an oligomer in cells. FTI-277 treatment had no effect on Spindly
expression levels, nor did it change the amount of endogenous Spindly that coimmunoprecipitated with Myc-tagged Spindly. Probing
the same immunoblot with anti-AG antibodies revealed efficient labeling of multiple farnesylated proteins in total cell lysates (input
lanes). MycGFP::SpindlyWT, but not MycGFP::SpindlyC602S, was
clearly detectable with anti-AG antibodies in both input and immunoprecipitated fractions. In addition, endogenous Spindly that coimmunoprecipitated with transgene-encoded Spindly could be detected with anti-AG antibodies in both MycGFP::SpindlyWT– and
MycGFP::SpindlyC602S–expressing cells. Treatment with FTI-277 abolished all anti-AG signal in cell lysates and immunoprecipitated fractions, demonstrating that AG incorporation into proteins is dependent on FTase activity. We conclude that Spindly is modified by FTase.
We also examined the farnesylation of endogenous CENP-E in
human DLD-1 cells and Xenopus egg extracts using the AG labeling
approach (Supplemental Figure S2, B and C). Endogenous CENP-E
incorporated AG after treatment with dimethyl sulfoxide (DMSO)
but not in the presence of FTI-277. In addition, MycGFP-tagged human CENP-E incorporated AG, whereas the farnesylation mutant
C2261S did not (Supplemental Figure S2D). Together, these data
confirm previous reports that CENP-E is farnesylated (Ashar et al.,
2000; Gurden et al., 2010).

Spindly farnesylation is required for its
kinetochore localization
It has been reported that CENP-E and CENP-F require farnesylation
for efficient targeting to kinetochores (Hussein and Taylor, 2002;
Molecular Biology of the Cell

Schafer-Hales et al., 2007). To determine whether Spindly localization to kinetochores requires FTase activity, we treated HeLa and
DLD-1 cells with FTI-277 and monitored Spindly localization by immunofluorescence. Microtubules were depolymerized with nocodazole, which causes Spindly and other components of the fibrous corona to accumulate at kinetochores (Hoffman et al., 2001).
In DMSO-treated cells arrested in mitosis with nocodazole, Spindly
adopted the expected crescent morphology at kinetochores (Figure
2A and Supplemental Figure S3A). By contrast, treatment with FTI277 reduced Spindly levels at kinetochores to 17 ± 3% (average ±
SEM with 95% confidence interval) in HeLa cells and to 17 ± 5% in
DLD-1 cells (Figure 2, A and D, and Supplemental Figure S3, A and
E). Under the same conditions, CENP-E kinetochore levels were reduced to 56 ± 7% in HeLa cells and 31 ± 7% in DLD-1 cells, whereas
CENP-F kinetochore levels were less affected, with a reduction to 73
± 10% in HeLa cells and 56 ± 10% in DLD-1 cells. (Figure 2, B–D, and
Supplemental Figure S3, B, C, and E). Kinetochore levels of Zwilch,
a subunit of the ROD/Zw10/Zwilch complex (Karess, 2005; Çivril
et al., 2010) that is required for kinetochore recruitment of Spindly,
were also reduced by FTI-277 treatment (80 ± 9% in HeLa cells;
Figure 2, E and G). By contrast, kinetochore levels of Hec1, a component of the KMN network that forms the core microtubule attachment site at the outer kinetochore (Cheeseman et al., 2006), were
not affected by FTI-277 treatment in either cell line (99 ± 12% and
98 ± 12% in HeLa and DLD-1 cells, respectively; Figure 2, F and G,
and Supplemental Figure S3, D and E). We conclude that FTase activity is a major requirement for kinetochore targeting of Spindly.
CENP-E and CENP-F also require farnesylation for proper kinetochore localization, but Spindly targeting to kinetochores is more severely affected by inhibition of farnesylation.
To test directly whether farnesylation of Spindly and CENP-E is
required for their recruitment to kinetochores, we examined the localization of farnesylation mutants. In the absence of nocodazole,
RNA interference (RNAi)–resistant MycGFP::SpindlyWT localized robustly to prometaphase kinetochores after RNAi-mediated depletion of endogenous Spindly, as expected (Gassmann et al., 2010;
Supplemental Figure S4A). By contrast, MycGFP::SpindlyC602S was
essentially undetectable at kinetochores of prometaphase cells in
the presence of microtubules (Supplemental Figure S4A), confirming the finding of a previous study that discussed the possibility that
Spindly is farnesylated (Barisic et al., 2010). However, analysis in cells
treated with nocodazole showed that the C602S mutant does retain
some ability to target to kinetochores in the absence of microtubule
attachment (Figure 2, H and I). Quantification of immunofluorescence signals revealed that the reduction in kinetochore levels of
MycGFP::SpindlyC602S (20 ± 3% of MycGFP::SpindlyWT) was similar to
the reduction observed for endogenous Spindly after FTI-277 treatment (17 ± 3% of DMSO control). The MycGFP::CENP-EC2261S mutant expressed in DLD-1 cells also showed reduced kinetochore
levels (45 ± 13% of MycGFP::CENP-EWT), which were not significantly different from kinetochore levels of MycGFP::CENP-EWT after
FTI-277 treatment (33 ± 8% of DMSO control; Supplemental Figure
S4, B and C). We conclude that modification by FTase is required for
proper kinetochore targeting of Spindly and CENP-E.

Inhibition of farnesylation impairs kinetochore recruitment
of dynein and dynactin
Spindly is required to target dynein and its cofactor dynactin to the
kinetochore, predicting that these proteins should be among the
kinetochore components whose levels are affected by FTI treatment. Indeed, we observed a significant decrease in kinetochore
levels of both dynein (DIC, 61 ± 8% of DMSO control) and dynactin
Volume 26 May 15, 2015

(p150, 65 ± 10% of DMSO control) in nocodazole-treated HeLa cells
after incubation with FTI-277 (Figure 3, A, B, and E). We also observed a reduction of kinetochore dynein and dynactin levels in cells
expressing MycGFP::SpindlyC602S to 66 ± 5% for dynein and 55 ± 8%
for dynactin relative to cells expressing MycGFP::SpindlyWT (Figure
3, C, D, and F). CENP-F is known to contribute to kinetochore dynein recruitment through the dynein cofactor NudE/L (Liang et al.,
2007; Stehman et al., 2007; Vergnolle and Taylor, 2007). To assess
whether the inhibition of CENP-F farnesylation could be contributing to the decrease of dynein/dynactin levels at kinetochores observed in FTI-treated cells, we added FTI-277 to cells expressing
MycGFP::SpindlyC602S. The FTI-277 treatment did not result in a significant additional decrease in dynein/dynactin levels (Figure 3F).
We conclude that inhibition of FTase reduces kinetochore levels of
dynein/dynactin and that this reduction is primarily a consequence
of preventing Spindly farnesylation.

CENP-E farnesylation is important for
chromosome segregation
Previous work showed that farnesylation is required for the degradation of CENP-E upon mitotic exit (Gurden et al., 2010). To determine
whether CENP-E farnesylation contributes to chromosome segregation, we took advantage of an RNAi-based replacement strategy
that we had established for CENP-E in DLD-1 cells (Kim et al., 2010).
We knocked down endogenous CENP-E with small interfering RNAs
(siRNAs) directed against the 3′ untranslated region of CENP-E
mRNA and induced expression of RNAi-resistant CENP-E transgenes with tetracycline (Figure 4A). Immunoblotting confirmed
efficient replacement of endogenous CENP-E with the transgeneencoded protein (Figure 4B), and endogenous CENP-E was undetectable at kinetochores in cells treated with CENP-E siRNAs by immunofluorescence (Figure 4C). We then monitored chromosome
segregation by time-lapse microscopy in cells coexpressing histone
H2B::mRFP. Depletion of CENP-E increased the average time cells
spent in mitosis, defined as the interval between nuclear envelope
breakdown and the onset of anaphase, from 58 min to 244 min on
average (Figure 4D). This mitotic delay was largely rescued by
MycGFP::CENP-EWT (67 min on average) but not when we replaced
endogenous CENP-E with the motor-dead rigor mutant T93N
(500 min on average), consistent with previously published data
(Kim et al., 2010). Replacement of endogenous CENP-E with the
farnesylation mutant C2261S led to a mitotic delay (120 min on average), which was less pronounced than that observed in cells treated
with FTI-277 (177 min on average; Figure 4E). Combining the CENPE C2261S mutant with FTI-277 treatment resulted in a mitotic delay
that was equal to FTI-277 treatment on its own (178 min on average). Inspection of the time-lapse movies confirmed that the mitotic
delay in cells treated with FTI-277 was caused by a defect in chromosome congression, similar to what was observed in CENP-E–depleted cells and in cells in which endogenous CENP-E was replaced
with the CENP-E C2261S mutant (Figure 4F). These results demonstrate that farnesylation of CENP-E is required for chromosome congression and timely mitotic progression but that inhibition of CENPE farnesylation alone cannot fully account for the mitotic phenotype
observed in cells treated with farnesyltransferase inhibitors.
A C-terminal CENP-E fragment (amino acids 1569–2264), called
the CENP-E tail, contains the kinetochore-binding domain and
causes a pronounced mitotic arrest when overexpressed (Chan
et al., 1998; Gurden et al., 2010; Supplemental Figure S5, A and B).
The mitotic delay in cells expressing the CENP-E tail in the presence
of endogenous CENP-E (1231 min on average) was significantly
more severe than in CENP-E–depleted cells (244 min on average;
Farnesylation of human Spindly
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FIGURE 1: Human Spindly interacts with and is modified by farnesyltransferase. (A) Results of mass spectrometric
analysis of immunoprecipitates from mitotic HeLa cells with two affinity-purified antibodies raised against nonoverlapping
N- and C-terminal epitopes of Spindly (amino acids 2–254 and 450–605). Sequence coverage and spectrum count for
selected proteins are shown. (B) Sequence alignment of Spindly C-termini in eukaryotes showing widespread
conservation of a putative farnesylation motif that deviates from the canonical CAAX box (Hougland et al., 2009). The
amino acid number of the fifth residue from the C-terminus is indicated. The farnesyl cysteine is present in vertebrates
(represented by Homo sapiens, Mus musculus, Gallus gallus, Xenopus laevis, Danio rerio). In the two invertebrate
chordate groups, the motif is present in tunicates (Ciona intestinalis) but is absent in amphioxus (B. floridae). Of the two
1848 | A. J. Holland et al.
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FIGURE 2: Farnesylation of Spindly is required for its localization to microtubule-unattached kinetochores. (A–C) HeLa
cells immunostained for the kinetochore proteins Spindly (A), CENP-E (B), and CENP-F (C) after treatment for 48 h with
10 μM farnesyltransferase inhibitor FTI-277 or DMSO. Cells were incubated in 1 μM nocodazole for 4 h to maximize the
accumulation of the proteins at kinetochores and costained with anti-centromere antibodies (ACAs). Scale bars, 5 μm.
(D) Quantification of protein levels at kinetochores in the conditions shown in A–C using immunofluorescence intensity
measurements. Each condition represents a total of 100 kinetochore measurements from 20 different cells. Error bars
represent the SEM with a 95% confidence interval. The t test was used to determine statistical significance (***p < 0.0001).
(E, F) HeLa cells immunostained for the kinetochore proteins Zwilch (E) and Hec1 (F) after treatment for 48 h with 10 μM
farnesyltransferase inhibitor FTI-277 or DMSO. Scale bars, 5 μm. (G) Kinetochore level quantification of the conditions in E
and F displayed as described for D (ns, not statistically significant). (H) Kinetochore localization of RNAi-resistant,
MycGFP-tagged wild-type (WT) and mutant (C602S) Spindly in nocodazole-treated HeLa cells after depletion of
endogenous Spindly, visualized by immunofluorescence with an anti-GFP antibody (see Figure 5A for corresponding RNAi
immunoblot). Scale bar, 5 μm. (I) Kinetochore level quantification of the condition in H displayed as described for D.

closest nonchordate invertebrate relatives of amphioxus, echinoderms (Strongylocentrotus purpuratus) have the motif
but hemichordates do not (S. kowalevskii). We could not find the motif in insects (D. melanogaster), nematodes
(C. elegans), or cnidaria (H. magnipapillata). However, the motif appears in the primitive multicellular animal Trichoplax
adhaerens, the only extant member of Placozoa, as well as in choanoflagellates (Monosiga brevicollis, Salpingoeca
spinifera), the closest unicellular relatives of multicellular animals. The motif is also present in the chytrid fungus
Batrachochytrium dendrobatidis. (C) Schematic of experimental approach for the detection of farnesylated Spindly based
on in vivo labeling with the unnatural farnesyl diphosphate analogue AGOH and AG-specific antibodies. (D) Immunoblots
detecting endogenous and transgenic Spindly and corresponding AG signals in cell lysate input fractions (I) and fractions
obtained after immunoprecipitation with anti-Myc tag antibody (Myc) or beads-only controls (Con).
Volume 26 May 15, 2015
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FIGURE 3: Farnesyltransferase inhibition or prevention of Spindly farnesylation impairs kinetochore recruitment of
dynein and its cofactor dynactin. (A–D) HeLa cells immunostained for dynein IC (DIC) and the dynactin subunit p150Glued
in cells treated with FTI-277 or DMSO (A, B) and in cells expressing wild-type (WT) and mutant (C602S) MycGFP::Spindly
after RNAi-mediated depletion of endogenous Spindly (C, D). Cells were incubated in 1 μM nocodazole for 4 h to
1850 | A. J. Holland et al.

Molecular Biology of the Cell

compare Figure 4D with Supplemental Figure S5B), suggesting that
the CENP-E tail is a gain-of-function mutant, possibly acting through
chronic activation of spindle assembly checkpoint signaling (Mao
et al., 2005). Strikingly, we observed that the dominant-negative effect of the CENP-E tail depends entirely on its modification by
FTase: expression of the CENP-E tail farnesylation mutant C2261S
had no adverse effect on mitotic duration (65 min on average), and
treatment with FTI-277 reduced the mitotic duration of cells expressing the CENP-E tail from 1231 min to 210 min on average,
which is close to the mitotic duration observed in FTI-277-treated
cells (177 min on average; Figure 4E and Supplemental Figure S5, A
and B). Furthermore, the C2261S mutation rescued the penetrant
lethality of CENP-E tail expression in a clonogenic survival assay
(Supplemental Figure S5C). This effect would not have been predicted from the comparatively mild functional consequences of inhibiting farnesylation of wild-type CENP-E and serves to demonstrate that inhibition of farnesylation can dramatically alter toxic
properties of mutant proteins.

Preventing farnesylation of Spindly and inhibition of
farnesyltransferase activity result in a similar mitotic
phenotype
The loss of Spindly from kinetochores after FTI-277 treatment indicated that nonfarnesylated Spindly contributes to the mitotic phenotype of FTase inhibitors. We tested this hypothesis by combining
specific depletion of endogenous Spindly with expression of RNAiresistant MycGFP::Spindly transgenes in HeLa cells coexpressing
H2B::mRFP (Figure 5A). As expected from previous work, the mitotic delay induced by depletion of Spindly (79 min on average) was
largely rescued by ectopic expression of MycGFP::SpindlyWT (40 vs.
28 min on average for control cells; Gassmann et al., 2010; Figure
5B). Expression of the MycGFP::SpindlyC602S mutant caused a mitotic delay (64 min on average), which was slightly less pronounced
than that observed in FTI-277-treated cells (71 min on average). Visualization of chromosome segregation confirmed that the mitotic
delay in cells expressing the MycGFP::SpindlyC602S mutant was
caused by misaligned chromosomes, a defect characteristic of Spindly depletions (Chan et al., 2009; Barisic et al., 2010; Gassmann
et al., 2010; Figure 5C). We conclude that farnesylation of Spindly is
required for efficient recruitment of dynein/dynactin to kinetochores
and timely chromosome congression.

DISCUSSION
FTase inhibitors (FTIs) are increasingly regarded as promising agents
for therapeutic intervention in a variety of diseases, which makes the
identification of a complete catalogue of FTase substrates an important goal. Previously it was shown that FTase inhibition leads to mitotic defects that have been largely attributed to a lack of farnesylation of the mitotic proteins CENP-E and CENP-F. Our study now
identifies Spindly as a third farnesylated mitotic protein and shows
that preventing farnesylation of Spindly is a major contributor to the
mitotic phenotype of FTIs.
CENP-E, CENP-F, and Spindly all localize to the fibrous corona at
the outer kinetochore, where Spindly and CENP-F are responsible
for the recruitment of cytoplasmic dynein and its cofactor dynactin.

The fibrous corona thus harbors multiple microtubule-binding activities that are required for efficient chromosome congression. Our
analysis shows that FTI treatment selectively perturbs the formation
of this kinetochore domain, whereas the core microtubule attachment site (represented in our experiments by Hec1) assembles normally. Although changes in kinetochore morphology are difficult to
quantify, we found that the telltale crescent and ring shapes of microtubule-unattached kinetochores (Hoffman et al., 2001) were
largely missing when staining for fibrous corona components after
FTI-277 treatment. Thus the decreased kinetochore levels of corona
components in the presence of FTIs may partially reflect the inability
of the fibrous corona domain to undergo expansion. Among the
three farnesylated kinetochore components, the localization of Spindly was the most dramatically affected by FTI treatment. We find
that the kinetochore recruitment of Spindly requires its farnesylation,
raising the possibility that the farnesyl moiety at the Spindly C-terminus is necessary for the interaction with a kinetochore receptor. Spindly kinetochore recruitment depends on the Rod/Zw10/Zwilch complex, and the C-terminus of human Spindly is positioned close to
Zwilch, Zw10, and the N-terminus of Rod, as determined by nanometer-scale immunofluorescence mapping experiments (Varma
et al., 2013). It will be interesting to investigate whether Spindly
farnesylation is required for binding to the Rod/Zw10/Zwilch complex. However, since the critical cysteine required for Spindly farnesylation is not present in all phyla, there are likely other conserved
regions of Spindly that participate in its kinetochore targeting.
Nevertheless, our work indicates that future biochemical reconstitution efforts of kinetochore complexes involving vertebrate Spindly
will need to take into account the key role of its farnesyl group.
There are contradictory reports regarding the contribution of
farnesylation to the kinetochore recruitment of CENP-E and CENPF, as previous studies did not measure kinetochore levels of these
proteins (Ashar et al., 2000; Crespo et al., 2001; Hussein and Taylor,
2002; Schafer-Hales et al., 2007; Verstraeten et al., 2011). Our experiments in HeLa and DLD-1 cells demonstrate that both CENP-E
and CENP-F require farnesylation for proper localization to microtubule-unattached kinetochores, although their localization is less affected by FTase inhibition than Spindly. We found that inhibition of
FTase also affects the localization of the ROD/Zw10/Zwilch complex,
which targets to the KMN network upstream of Spindly. The expansion of the fibrous corona in the absence of microtubules is not understood at the molecular level, but it is evident that the expansion
step must involve interactions among corona components that are
distinct from the interactions that mediate the initial recruitment by
the KMN network, which itself does not expand. One interpretation
of our results is that the kinetochore accumulation of the ROD/
Zw10/Zwilch complex in the absence of microtubules is in part facilitated by interactions with CENP-E, CENP-F, or Spindly, whose kinetochore recruitment is directly affected by FTI treatment.
Our molecular replacement experiments establish that both nonfarnesylated CENP-E and nonfarnesylated Spindly cause chromosome congression defects and contribute to the delay in mitotic progression that is observed after FTI treatment. Assessing the functional
significance of CENP-F farnesylation for chromosome segregation
will necessitate the development of a molecular replacement

maximize the accumulation of the proteins at kinetochores and costained with ACAs. Scale bars, 5 μm.
(E, F) Quantification of dynein and dynactin levels at kinetochores in the conditions shown in A–D, as well as in the
Spindly mutant C602S after treatment with FTI-277, using immunofluorescence intensity measurements. Each condition
represents a total of 100 kinetochore measurements from 20 different cells. Error bars represent the SEM with a 95%
confidence interval. The t test was used to determine statistical significance (***p < 0.0001; ns, not significant).
Volume 26 May 15, 2015

Farnesylation of human Spindly

| 1851

FIGURE 4: CENP-E farnesylation is important for chromosome segregation. (A) Experimental approach for the
characterization of DLD-1 Flp-In T-Rex cells with integrated RNAi-resistant CENP-E constructs whose expression is
inducible with tetracycline. (B) Immunoblot showing successful replacement of endogenous CENP-E with RNAi-resistant
MycGFP::CENP-E in DLD-1 cells. C2261S corresponds to the CENP-E farnesylation mutant and T93N to motor-dead
“rigor” CENP-E. α-Tubulin was used as a loading control. (C) Immunofluorescence of DLD-1 cells showing loss of
kinetochore-localized CENP-E 48 h after transfection with CENP-E siRNA. Cells were costained with ACAs. Scale bar,
5 μm. (D) Quantification of mitotic duration (nuclear envelope breakdown to anaphase onset) from time-lapse
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approach similar to the one we used here. Of interest, FTI treatment
in DLD-1 cells had a more pronounced effect on kinetochore levels of
CENP-E and CENP-F than FTI treatment in HeLa cells, yet the mitotic
delay caused by FTase inhibition was similar in both cell lines
(2.2- and 2.5-fold in DLD-1 and HeLa cells, respectively). Taking this
together with the observation that nonfarnesylated Spindly was
robustly displaced from kinetochores in both cell lines, we propose
that loss of Spindly farnesylation is a major factor contributing to the
mitotic phenotype observed in cells treated with FTIs.

MATERIALS AND METHODS
Cells lines and antibodies
Stable isogenic cell lines expressing Spindly and CENP-E transgenes were generated by FRT/Flp-mediated recombination as described previously (Tighe et al., 2004). Full-length Spindly and
CENP-E cDNA corresponding to amino acids 1569–2264 of CENPE (CENP-E tail) were cloned into a pcDNA5/FRT/TO-based vector
(Invitrogen, Carlsbad, CA) modified to contain an N-terminal
Myc-LAP epitope tag. The LAP tag consists of GFP-TEV-S-peptide
(Cheeseman et al., 2004). Affinity-purified rabbit polyclonal antibodies against Spindly fragments comprising amino acids 2–254
(OD173) and 450–605 (OD174) were generated as described previously (Desai et al., 2003).

Cell culture and RNA interference
HeLa and DLD-1 cells were maintained at 37°C in a 5% CO2 atmosphere in DMEM (Thermo Fischer Scientific, Waltham, MA) supplemented with 10% tetracycline-free fetal bovine serum (Clontech,
Mountain View, CA), 100 U/ml penicillin, 100 U/ml streptomycin,
and 2 mM l-glutamine. For immunofluorescence, cells were seeded
on 12-mm poly-l-lysine–coated coverslips in 12-well plates 24 h before transfection with siRNAs. For live-cell imaging experiments,
cells were seeded in a 35-mm glass-bottom dish coated with poly-dlysine (MatTek, Ashland, MA). Cells were transfected with siRNAs
targeting Spindly and the CENP-E 3′ UTR as described previously
(Gassmann et al., 2010; Kim et al., 2010). For immunofluorescence
of HeLa Flp-In T-Rex cells, transgene expression was induced with
0.2 μg/ml tetracycline 24 h posttransfection, and cells were fixed
20–24 h later. For live-cell imaging of HeLa Flp-In T-Rex cells and for
the immunoblot shown in Figure 5A, transgene expression was induced 22 h after transfection, and time-lapse imaging experiments
were started 8 h later.

AGOH labeling and drug treatments
For labeling of DLD-1 or HeLa Flp-In T-Rex cells with the farnesol
analogue AGOH, a confluent 10-cm dish of unsynchronized cells
was split 1:5 into one 15-cm dish. After 24 h, cells were incubated
with 30 μM AGOH, 0.2 μg/ml tetracycline, and 10 μM FTI-277
(Sigma-Aldrich, St. Louis, MO) for 40 h before cells were harvested
and processed for immunoprecipitation experiments and immuno
blotting. To depolymerize microtubules before immunofluorescence, cells were treated with 1 μM nocodazole for 4 h.

Immunoprecipitations and mass spectrometry
For mass spectrometry analysis of Spindly immunoprecipitates, endogenous Spindly was immunoprecipitated with 50 μg of affinitypurified anti-Spindly antibody OD173 or OD174 (covalently coupled
to 100 μl of agarose protein A beads [BioRad, Hercules, CA]) from a
mitotic HeLa cell extract (30 mg of total protein). The extract was
prepared by sonicating nocodazole-arrested cells (harvested by mitotic shake-off) in lysis buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], pH 7.6, 200 mM KCl, 1 mM MgCl2,
1 mM ethylene glycol tetraacetic acid [EGTA], 5% glycerol, 0.05%
NP-40, 1 mM dithiothreitol [DTT], 5 mM β-glycerophosphate, 400 nM
microcystin, and cOmplete protein inhibitor cocktail [Roche, Basel,
Switzerland]), followed by sequential rounds of centrifugation in an
ultracentrifuge at 20,000 and 50,000 × g. Beads were washed with
6 × 1 ml of lysis buffer and 3 × 1 ml of lysis buffer without detergent.
Proteins were eluted from beads with 0.1 M glycine, pH 2.6, and the
samples neutralized with 2 M Tris-HCl, pH 8.5. Proteins were precipitated by addition of 1/5 volume trichloroacetic acid (TCA) overnight
on ice, and the TCA pellet was washed twice with acetone before
air-drying. Mass spectrometry was conducted as described previously (Cheeseman et al., 2004).
For immunoprecipitations from HeLa cells after labeling with the
farnesol analogue AGOH, unsynchronized cells (one 15-cm dish per
condition) were harvested, washed with 1× phosphate-buffered saline (PBS), and sonicated in 3 ml of lysis buffer (50 mM HEPES, pH 7.4,
200 mM KCl, 1 mM EGTA, 1 mM MgCl2, 0.05% NP-40, 1 mM DTT,
5 mM β-glycerophosphate, and protease inhibitors). The crude lysate was clarified by spinning at 20,000 × g for 10 min, and 1.3 ml of
the cleared lysate was incubated with 5 μg of anti-Myc tag antibody
(clone 4A6) covalently coupled to 10 μl of agarose protein A beads
(or with protein A beads alone as a control) for 2 h at 4°C. After washing of the beads with 3 × 1 ml of lysis buffer, proteins were eluted
with SDS–PAGE sample buffer without DTT (50 mM Tris-HCl, pH 6.8,
15% [wt/vol] sucrose, 2 mM EDTA, 3% SDS) at 70°C for 15 min.

Live-cell imaging
For live-cell imaging, growth medium was replaced with CO2-independent medium (Thermo Fischer Scientific) supplemented with
0.2 μg/ml tetracycline immediately before filming and covered with
a layer of mineral oil. Time-lapse sequences were recorded on a
DeltaVision microscope (Applied Precision, Mississauga, Canada)
equipped with an environmental chamber heated to 36–37°C as
measured in the dish. Image stacks of 5 × 3 μm were acquired every
4 min for 10 h with a CoolSnap charge-coupled device camera
(Photometrics, Tuscon, AZ) and a 40×/numerical aperture (NA) 1.35
U-planApo objective (Olympus, Tokyo, Japan) at 2 × 2 binning.

Indirect immunofluorescence and immunoblotting
For immunofluorescence experiments, cells were fixed immediately
after aspiration of the medium with 4% formaldehyde in Phem buffer
(60 mM 1,4-piperazinediethanesulfonic acid, 25 mM HEPES, 10 mM
EGTA, 2 mM MgCl2, pH 6.9) for 5 min at room temperature and then

fluorescence microscopy experiments conducted with DLD-1 cells expressing histone H2b::mRFP with or without the
CENP-E transgenes described in B. Mitotic duration is shown as a scatter plot with the average and SD for the indicated
experimental conditions. All conditions were filmed in parallel during the same imaging session using a multiwell
chamber. One hundred cells were scored for each condition. The t test was used to determine statistical significance
(***p < 0.0001). (E) Quantification of mitotic duration for the indicated conditions from a time-lapse experiment, as
described in D (ns, not statistically significant). (F) Selected images from a time-lapse series of DLD-1 cells coexpressing
histone H2b::mRFP and CENP-E transgenes showing chromosome congression defects in cells expressing
nonfarnesylated CENP-E. Time is indicated in minutes relative to nuclear envelope breakdown (time point 0). Lowercase
letters refer to the conditions labeled with the same letters in D and E. Scale bar, 5 μm.
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permeabilized for 2 min with 0.1% Triton
X-100 in Phem buffer and rinsed three times
in Phem buffer. For stainings with anti-dynein antibodies, cells were fixed in methanol
at −20°C for 45 min, followed by rehydration
for 2 × 5 min in PBS/0.5% Triton X-100 and
PBS/0.1% Triton X-100. Cells were blocked
for 30 min in AbDil solution (4% immunoglobulin G–free bovine serum albumin
[Jackson Immuno
Research, West Grove,
PA], 0.1% Triton X-100) and incubated with
primary antibody for 1 h at room temperature (overnight at 4°C for anti-dynein), diluted in AbDil (human anti–centromere antibodies [ACAs], 1:1000; rabbit anti-AG,
1:1000; mouse anti-CENP-E 1H12, 1:500;
sheep anti-CENP-F, 1:800; mouse anti-dynein IC 70.1, 1:500; mouse anti-dynactin
p150, 1:150; goat anti-GFP, 1:15000; mouse
anti-Hec1 9G3, 1:1000; rabbit anti-Spindly
OD174, 1:5000; rabbit anti-Zwilch, 1:900).
After washing for 3 × 5 min in PBS/0.1%
Triton X-100, cells were incubated with secondary antibodies conjugated with fluorescent dyes (Alexa 488, rhodamine red X, Cy5
[Jackson ImmunoResearch]). Cells were
washed again for 3 × 5 min and mounted in
Prolong Gold with 4′,6-diamidino-2-phenylindole stain (Invitrogen). Images were recorded on an Axio Observer microscope
(Carl Zeiss, Oberkochen, Germany) at 1 × 1
binning with a 100×/NA 1.46 Plan-Apochromat objective and an Orca Flash 4.0 camera
(Hamamatsu Photonics, Hamamatsu, Japan).
Maximum intensity projections of z-stacks
were imported into Photoshop CS5.1
(Adobe Systems, San Jose, CA) for further
processing. For quantification of kinetochore signals, unprocessed 16-bit images
were analyzed with Fiji software as described

FIGURE 5: Preventing farnesylation of Spindly and inhibiting farnesyltransferase result in a
similar mitotic delay. (A) Immunoblot showing expression levels of endogenous and RNAiresistant, transgene-encoded MycGFP::Spindly. Cells were treated with control or Spindly siRNA
for 22 h, followed by induction of transgene expression with 0.2 μg/ml tetracycline for 8 h.
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α-Tubulin was used as a loading control.
(B) Quantitative analysis of mitotic duration
(nuclear envelope breakdown to anaphase
onset) for time-lapse fluorescence
microscopy experiments performed with
HeLa cells expressing histone H2b::mRFP
with or without Spindly transgenes. RNAi and
induction of transgene expression was
performed as for the immunoblot in A. Data
are shown as scatter plots with average and
SD. Two independent experiments were
performed for each condition, and the total
number (n) of cells scored is indicated. The
t test was used to determine statistical
significance (***p < 0.0001; *p < 0.05).
(C) Selected images from the time-lapse
experiments described in B, showing
chromosome congression defects in cells
expressing the Spindly farnesylation mutant
C602S. Time is indicated in minutes relative
to nuclear envelope breakdown (time point
0). Scale bar, 5 μm.
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previously (Hoffman et al., 2001). At each kinetochore, the signal
intensity of the outer kinetochore component was normalized to the
signal intensity of ACAs.
Immunoblotting was performed using standard methods with
horseradish peroxidase–coupled secondary antibodies (Jackson ImmunoResearch) and ECL (GE Healthcare, Little Chalfont, United
Kingdom) following the manufacturer’s instructions. Primary antibodies were rabbit anti-AG (1:1000), rabbit anti-Spindly OD157
(1:3000), mouse anti–α-tubulin (DM1α, 1:1000), rabbit anti-CENP-E
(1:1000), mouse anti-Mad1 (1:10), and rabbit anti-Mad2 (1:100).

Statistical analysis
Statistical significance was evaluated with the t test using Prism 6
software (GraphPad, La Jolla, CA).
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